| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adult pneumococcal vaccination: what are the gaps?
|
von Mollendorf, Claire
|
|
|
24 |
10 |
p. 1068-1069
|
artikel
|
| 2 |
Antiblackness in the Ebola response in Sierra Leone
|
Haslam, Elizabeth
|
|
|
24 |
10 |
p. 1081
|
artikel
|
| 3 |
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
|
Wang, Huwen
|
|
|
24 |
10 |
p. 1130-1140
|
artikel
|
| 4 |
Biopolitical precarity for women with HIV in South Africa
|
Starbuck, Emma
|
|
|
24 |
10 |
p. 1080
|
artikel
|
| 5 |
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
|
Silk, Sarah E
|
|
|
24 |
10 |
p. 1105-1117
|
artikel
|
| 6 |
Bolstering influenza protection for older adults
|
Sambhara, Suryaprakash
|
|
|
24 |
10 |
p. 1064-1066
|
artikel
|
| 7 |
Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south
|
Wannigama, Dhammika Leshan
|
|
|
24 |
10 |
p. e610-e613
|
artikel
|
| 8 |
Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study
|
Tamarozzi, Francesca
|
|
|
24 |
10 |
p. e627-e637
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2024; 24: e484
|
|
|
|
24 |
10 |
p. e618
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2024; published online Aug 12. https://doi.org/10.1016/S1473-3099(24)00357-8
|
|
|
|
24 |
10 |
p. e618
|
artikel
|
| 11 |
Doxycycline for STIs in men who have sex with men: the next steps
|
Grennan, Troy
|
|
|
24 |
10 |
p. 1061-1063
|
artikel
|
| 12 |
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design
|
Molina, Jean-Michel
|
|
|
24 |
10 |
p. 1093-1104
|
artikel
|
| 13 |
doxyPEP: a controversial new tool against STIs
|
The Lancet Infectious Diseases,
|
|
|
24 |
10 |
p. 1059
|
artikel
|
| 14 |
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
|
Korotych, Oleksandr
|
|
|
24 |
10 |
p. 1151-1161
|
artikel
|
| 15 |
Enhancing wastewater testing for H5N1 surveillance
|
Dhillon, Ranu S
|
|
|
24 |
10 |
p. e608
|
artikel
|
| 16 |
Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity
|
Mercuri, Mathew
|
|
|
24 |
10 |
p. e654-e658
|
artikel
|
| 17 |
Facing COVID-19 in South Africa
|
Blott, Jonathan
|
|
|
24 |
10 |
p. 1077
|
artikel
|
| 18 |
Farah Qamar—tackling paediatric infectious diseases
|
Kirby, Tony
|
|
|
24 |
10 |
p. 1076
|
artikel
|
| 19 |
First diagnoses of Oropouche virus in Europe: how can we strengthen communication and preparedness globally?
|
Castilletti, Concetta
|
|
|
24 |
10 |
p. e602-e603
|
artikel
|
| 20 |
First report of deep cutaneous fungal infection caused by Nigrograna hydei
|
Wang, Shu-Fen
|
|
|
24 |
10 |
p. e659
|
artikel
|
| 21 |
Getting closer to an effective multi-stage malaria vaccine
|
Dobaño, Carlota
|
|
|
24 |
10 |
p. 1063-1064
|
artikel
|
| 22 |
Global update on hypervirulent Klebsiella pneumoniae
|
Das, Manjulika
|
|
|
24 |
10 |
p. e621
|
artikel
|
| 23 |
Global upsurge in dengue in 2024
|
Venkatesan, Priya
|
|
|
24 |
10 |
p. e620
|
artikel
|
| 24 |
Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues
|
Raccagni, Angelo Roberto
|
|
|
24 |
10 |
p. e614-e615
|
artikel
|
| 25 |
HIV stigma in health-care settings in Europe and central Asia
|
Bagcchi, Sanjeet
|
|
|
24 |
10 |
p. e622
|
artikel
|
| 26 |
Implementing long-acting injectable cabotegravir and rilpivirine in Africa
|
Orkin, Chloe
|
|
|
24 |
10 |
p. 1060-1061
|
artikel
|
| 27 |
Infectious diseases surveillance update
|
Islam, Tanzina
|
|
|
24 |
10 |
p. e625
|
artikel
|
| 28 |
Living with our distant relatives
|
Lenahan, Claire
|
|
|
24 |
10 |
p. 1078
|
artikel
|
| 29 |
Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis
|
Decroo, Tom
|
|
|
24 |
10 |
p. 1069-1071
|
artikel
|
| 30 |
Mpox emergency in Africa
|
Nakkazi, Esther
|
|
|
24 |
10 |
p. e619
|
artikel
|
| 31 |
Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection
|
Soriano, Vicente
|
|
|
24 |
10 |
p. 1066-1067
|
artikel
|
| 32 |
Polio vaccination campaign in Gaza
|
Burki, Talha
|
|
|
24 |
10 |
p. e623-e624
|
artikel
|
| 33 |
Re-evaluating polio vaccination strategies in Nepal: transitioning from OPV to fIPV for sustained immunity
|
Saud, Bhuvan
|
|
|
24 |
10 |
p. 1073-1074
|
artikel
|
| 34 |
Research in brief
|
Venkatesan, Priya
|
|
|
24 |
10 |
p. e626
|
artikel
|
| 35 |
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial
|
Eiden, Joseph
|
|
|
24 |
10 |
p. 1118-1129
|
artikel
|
| 36 |
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial
|
Platt, Heather L
|
|
|
24 |
10 |
p. 1141-1150
|
artikel
|
| 37 |
Social histories of public health misinformation and infodemics: case studies of four pandemics
|
Jin, Sabrina L
|
|
|
24 |
10 |
p. e638-e646
|
artikel
|
| 38 |
Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance
|
Vanbaelen, Thibaut
|
|
|
24 |
10 |
p. e606-e607
|
artikel
|
| 39 |
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
|
Kityo, Cissy
|
|
|
24 |
10 |
p. 1083-1092
|
artikel
|
| 40 |
Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis
|
Schwab, Tiana Carina
|
|
|
24 |
10 |
p. 1162-1176
|
artikel
|
| 41 |
Tengiz Tsertsvadze
|
Bagcchi, Sanjeet
|
|
|
24 |
10 |
p. 1075
|
artikel
|
| 42 |
The global alarm bell is ringing due to the threat of potential severe cases and deaths caused by clade I of monkeypox virus
|
Du, Min
|
|
|
24 |
10 |
p. e616-e617
|
artikel
|
| 43 |
Time to change to next-generation sequencing for management of drug-resistant tuberculosis?
|
Van Rie, Annelies
|
|
|
24 |
10 |
p. 1071-1072
|
artikel
|
| 44 |
Tracking the spread of avian influenza A(H5N1) with alternative surveillance methods: the example of wastewater data
|
Branda, Francesco
|
|
|
24 |
10 |
p. e604-e605
|
artikel
|
| 45 |
Tuberculosis in the USA in 1935
|
Bagcchi, Sanjeet
|
|
|
24 |
10 |
p. 1082
|
artikel
|
| 46 |
Understanding outbreak preparedness
|
Das, Manjulika
|
|
|
24 |
10 |
p. 1079
|
artikel
|
| 47 |
Urgent considerations for booster vaccination strategies against Ebola virus disease
|
Adriaensen, Wim
|
|
|
24 |
10 |
p. e647-e653
|
artikel
|
| 48 |
Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant
|
Kaku, Yu
|
|
|
24 |
10 |
p. e609
|
artikel
|
Tijdschrift beschrijving